Krebs Biochemicals & Industries Surges to 52-Week High, Outperforms Sector
Krebs Biochemicals & Industries, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on July 18th, 2024. Despite a 'Sell' call from MarketsMojo, the company has outperformed its sector and has been on a consecutive gain streak for the past 5 days. It is currently trading above its moving averages and has shown a 19.44% increase in the past year, showcasing its stability and potential for growth in the pharmaceutical industry.
Krebs Biochemicals & Industries, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on July 18th, 2024. This has caught the attention of investors and market analysts, with MarketsMOJO giving a 'Sell' call for the stock.
Despite this, the company has outperformed its sector by 1.75% and has been on a consecutive gain streak for the past 5 days, with a 9.77% increase in returns during this period. The stock also touched an intraday high of Rs 87.05, showing a 2.04% increase.
In terms of moving averages, Krebs Biochemicals & Industries is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates a positive trend for the company's stock.
Looking at the company's performance over the past year, Krebs Biochemicals & Industries has shown a 19.44% increase, slightly lower than the Sensex's performance of 21.00%. This showcases the company's stability and potential for growth in the pharmaceutical industry.
Overall, Krebs Biochemicals & Industries has been making positive strides in the market, with its recent stock price surge and consistent gains. Investors and analysts will continue to monitor the company's performance and future developments in the pharmaceutical sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
